Business Wire

NanoVibronix Advances Development of PainShield and UroShield with Completion of NextGen Prototypes

ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV) (the “Company”), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) ...
Nasdaq

NanoVibronix Enters into Letter of Intent with APOGEPHA Arzneimittel GmbH to Explore European Distribution Opportunity

ELMSFORD, N.Y.--(BUSINESS WIRE)-- NanoVibronix, Inc. (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic ...
Hosted on MSN

NanoVibronix stock touches 52-week low at $0.44 amid market challenges

NanoVibronix Inc. (NAOV), a medical device company with a market capitalization of $1.73 million, saw its stock price touch a 52-week low of $0.44, reflecting a challenging period for the firm.
Nasdaq

ENvue Medical Granted U.S. Patent for Pediatric Feeding Tube Guidance System

TYLER, Texas--(BUSINESS WIRE)-- NanoVibronix, Inc. (NASDAQ: NAOV) (“NanoVibronix” or the “Company”), a medical technology company specializing in therapeutic devices, announced today, through its ...
The Globe and Mail

ENvue Medical, Formerly NanoVibronix, UroShield® Kit Secures Reimbursement in the UK

TYLER, Texas, Dec. 18, 2025 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ: FEED) (NASDAQ: NAOV) (“ENvue,” “ENvue Medical” or the “Company”), a medical ...
Forbes

The Evolution Of Medical Device Products In A Consumer-Driven World

Fueled by convenience, fashion, size and technical innovation, medical devices have evolved from clinical settings to daily consumer use. Today’s highly personalized devices are being embedded into ...